Consolidated Statements of Income - USD ($)	12 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Net revenues	$ 3,754,212	$ 5,271,231
Cost of sales	1,865,908	2,611,493
Gross profit	1,888,304	2,659,738
Operating expenses:
Research and development	527,659	168,812
Selling, general and administrative	1,404,604	1,241,991
Stock based compensation		98,600
Depreciation and amortization	22,229	11,774
Total operating expenses	1,954,492	1,521,177
Income (loss) from operations	(66,188)	1,138,561
Other income (expense):
Interest income	17,632	3,146
Interest expense	(6,707)	(4,947)
Total other income (expense)	10,925	(1,801)
Income (loss) before (provision) benefit for income taxes	(55,263)	1,136,760
(Provision) benefit for income taxes:
Current	(1,000)
Deferred	166,000	69,000
Total benefit for income taxes	165,000	69,000
Net income	$ 109,737	$ 1,205,760
Basic and diluted earnings per common share: (in dollars per share)	$ 0	$ 0.02
Weighted average shares of common stock outstanding - basic (in shares)	67,588,504	67,145,150
Weighted average shares of common stock outstanding - diluted (in shares)	67,588,504	67,145,150